A Reversal for Amarin Corporation Plc – American Depositary Share (NASDAQ:AMRN) Is Near. The Stock Has Decrease in Shorts

June 18, 2018 - By Peter Erickson

Amarin Corporation plc (NASDAQ:AMRN) Logo

Investors sentiment decreased to 1.05 in 2018 Q1. Its down 0.17, from 1.22 in 2017Q4. It fall, as 16 investors sold Amarin Corporation plc shares while 28 reduced holdings. 15 funds opened positions while 31 raised stakes. 113.30 million shares or 2.50% more from 110.54 million shares in 2017Q4 were reported.
Loring Wolcott And Coolidge Fiduciary Llp Ma has 0% invested in Amarin Corporation plc (NASDAQ:AMRN). Cetera accumulated 14,670 shares. Moreover, Comerica Fincl Bank has 0% invested in Amarin Corporation plc (NASDAQ:AMRN). Cambridge Investment Research reported 0% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN). Architects stated it has 10,000 shares or 0.01% of all its holdings. Dumont & Blake Limited Liability Company holds 0.03% in Amarin Corporation plc (NASDAQ:AMRN) or 23,000 shares. Comml Bank Of Montreal Can owns 31,000 shares for 0% of their portfolio. Farallon Cap Lc invested in 4.56 million shares. Broadfin Capital Ltd Limited Liability Company stated it has 0.98% in Amarin Corporation plc (NASDAQ:AMRN). 202,997 are owned by State Street Corporation. Geode Capital Mngmt Limited Com invested 0% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN). Perkins Cap Mgmt has invested 0.12% in Amarin Corporation plc (NASDAQ:AMRN). Raymond James Advsr holds 0% or 279,117 shares in its portfolio. Reilly Finance Advisors Limited Co holds 0.01% or 16,000 shares. D E Shaw & Inc stated it has 59,431 shares or 0% of all its holdings.

Since January 2, 2018, it had 0 insider buys, and 7 insider sales for $1.89 million activity. Ketchum Steven B sold 2,612 shares worth $11,493.

The stock of Amarin Corporation Plc – American Depositary Share (NASDAQ:AMRN) registered a decrease of 54.34% in short interest. AMRN’s total short interest was 3.45M shares in June as published by FINRA. Its down 54.34% from 7.57M shares, reported previously. With 3.17M shares average volume, it will take short sellers 1 days to cover their AMRN’s short positions. The short interest to Amarin Corporation Plc – American Depositary Share’s float is 1.76%.

The stock decreased 0.62% or $0.02 during the last trading session, reaching $3.23. About 1.22 million shares traded. Amarin Corporation plc (NASDAQ:AMRN) has risen 0.66% since June 18, 2017 and is uptrending. It has underperformed by 11.91% the S&P500.

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company has market cap of $948.28 million. The companyÂ’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It currently has negative earnings. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels.

Amarin Corporation plc (NASDAQ:AMRN) Ratings Coverage

Among 2 analysts covering Amarin (NASDAQ:AMRN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Amarin has $10.0 highest and $1000 lowest target. $10’s average target is 209.60% above currents $3.23 stock price. Amarin had 3 analyst reports since March 1, 2018 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Buy” rating and $1000 target in Wednesday, May 2 report. The firm has “Buy” rating by H.C. Wainwright given on Thursday, March 1. H.C. Wainwright maintained the stock with “Buy” rating in Thursday, May 3 report.

More important recent Amarin Corporation plc (NASDAQ:AMRN) news were published by: Globenewswire.com which released: “Amarin Announces Patent Litigation Settlement Agreement with Teva” on May 24, 2018, also Streetinsider.com published article titled: “Amarin Corp. (AMRN) to Collaborate with Mochida Pharmaceutical Co. on Future Development of EPA-based Drug …”, Nasdaq.com published: “Research Report Identifies Diodes, Arbutus Biopharma, Radware, Immutep, Amarin, and SPS Commerce with …” on June 06, 2018. More interesting news about Amarin Corporation plc (NASDAQ:AMRN) was released by: Seekingalpha.com and their article: “Amarin Continues To Chug Along” with publication date: May 29, 2018.

Amarin Corporation plc (NASDAQ:AMRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: